# OnCo record paper-checkmate-238-lancet-oncol-2020-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-238-lancet-oncol-2020-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-238-lancet-oncol-2020-update" ;
  schema:name "Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial"@en ;
  schema:description "Later report from the CheckMate 238 trial registered as NCT02388906, in The Lancet Oncology (2020); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-238-lancet-oncol-2020-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s1470-2045(20)30494-0>, <https://pubmed.ncbi.nlm.nih.gov/32961119/>, <https://europepmc.org/article/MED/32961119>, <https://clinicaltrials.gov/study/NCT02388906> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s1470-2045(20)30494-0> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Ascierto PA, Del Vecchio M, Mandalá M, et al." ;
  onco:trials <https://onco.cc/trials/checkmate-238/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .